Cross-linked Hyaluronic Acid in AVALON™ Fillers

MCO™ Tech. (Minimising Cross-linking-agent by Optimising reaction Technology) is a technology developed by Koru Pharma’s R&D Institute.
The cross-linking agent serves to connect hyaluronic acid chains to form a net.
Through optimisation of cross-linking reaction conditions in which a chemical reaction between the cross-linking agent and HA occurs, the use of the cross-linking agent is minimised, thereby maximising the efficiency of the cross-linking reaction.